世界の転移性骨がん薬物治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Metastatic Bones Cancer Medication Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5856 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、転移性骨がん薬物治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、ビスフォスフォネート、アヘン剤療法、免疫療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・転移性骨がん薬物治療の市場動向 ・企業の競争状況、市場シェア ・転移性骨がん薬物治療の種類別市場規模と予測2016-2027（化学療法、ホルモン療法、ビスフォスフォネート、アヘン剤療法、免疫療法） ・転移性骨がん薬物治療の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・転移性骨がん薬物治療の北米市場規模2016-2027（アメリカ、カナダ） ・転移性骨がん薬物治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・転移性骨がん薬物治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・転移性骨がん薬物治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・転移性骨がん薬物治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Merck & Co、Roche、Novartis、Eli Lilly and Company、Bayer、Fresenius Kabi、BTG plc、Boston Scientific、Medtronic） ・結論

Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancer

Market Analysis and Insights: Global Metastatic Bones Cancer Medication Treatment Market
The global Metastatic Bones Cancer Medication Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Bones Cancer Medication Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Bones Cancer Medication Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Bones Cancer Medication Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Bones Cancer Medication Treatment market.

Global Metastatic Bones Cancer Medication Treatment Scope and Market Size
Metastatic Bones Cancer Medication Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Bones Cancer Medication Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Hormone Therapy
Bisphosphonates
Opiate Therapy
Immunotherapy

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen
Merck & Co
Roche
Novartis
Eli Lilly and Company
Bayer
Fresenius Kabi
BTG plc
Boston Scientific
Medtronic

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Bones Cancer Medication Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Hormone Therapy
1.2.4 Bisphosphonates
1.2.5 Opiate Therapy
1.2.6 Immunotherapy
1.3 Market by Application
1.3.1 Global Metastatic Bones Cancer Medication Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metastatic Bones Cancer Medication Treatment Market Perspective (2016-2027)
2.2 Metastatic Bones Cancer Medication Treatment Growth Trends by Regions
2.2.1 Metastatic Bones Cancer Medication Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metastatic Bones Cancer Medication Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Metastatic Bones Cancer Medication Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Metastatic Bones Cancer Medication Treatment Industry Dynamic
2.3.1 Metastatic Bones Cancer Medication Treatment Market Trends
2.3.2 Metastatic Bones Cancer Medication Treatment Market Drivers
2.3.3 Metastatic Bones Cancer Medication Treatment Market Challenges
2.3.4 Metastatic Bones Cancer Medication Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metastatic Bones Cancer Medication Treatment Players by Revenue
3.1.1 Global Top Metastatic Bones Cancer Medication Treatment Players by Revenue (2016-2021)
3.1.2 Global Metastatic Bones Cancer Medication Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Metastatic Bones Cancer Medication Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastatic Bones Cancer Medication Treatment Revenue
3.4 Global Metastatic Bones Cancer Medication Treatment Market Concentration Ratio
3.4.1 Global Metastatic Bones Cancer Medication Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Bones Cancer Medication Treatment Revenue in 2020
3.5 Metastatic Bones Cancer Medication Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Bones Cancer Medication Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Bones Cancer Medication Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Bones Cancer Medication Treatment Breakdown Data by Type
4.1 Global Metastatic Bones Cancer Medication Treatment Historic Market Size by Type (2016-2021)
4.2 Global Metastatic Bones Cancer Medication Treatment Forecasted Market Size by Type (2022-2027)

5 Metastatic Bones Cancer Medication Treatment Breakdown Data by Application
5.1 Global Metastatic Bones Cancer Medication Treatment Historic Market Size by Application (2016-2021)
5.2 Global Metastatic Bones Cancer Medication Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metastatic Bones Cancer Medication Treatment Market Size (2016-2027)
6.2 North America Metastatic Bones Cancer Medication Treatment Market Size by Type
6.2.1 North America Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2021)
6.2.2 North America Metastatic Bones Cancer Medication Treatment Market Size by Type (2022-2027)
6.2.3 North America Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2027)
6.3 North America Metastatic Bones Cancer Medication Treatment Market Size by Application
6.3.1 North America Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2021)
6.3.2 North America Metastatic Bones Cancer Medication Treatment Market Size by Application (2022-2027)
6.3.3 North America Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2027)
6.4 North America Metastatic Bones Cancer Medication Treatment Market Size by Country
6.4.1 North America Metastatic Bones Cancer Medication Treatment Market Size by Country (2016-2021)
6.4.2 North America Metastatic Bones Cancer Medication Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Metastatic Bones Cancer Medication Treatment Market Size (2016-2027)
7.2 Europe Metastatic Bones Cancer Medication Treatment Market Size by Type
7.2.1 Europe Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2021)
7.2.2 Europe Metastatic Bones Cancer Medication Treatment Market Size by Type (2022-2027)
7.2.3 Europe Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2027)
7.3 Europe Metastatic Bones Cancer Medication Treatment Market Size by Application
7.3.1 Europe Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2021)
7.3.2 Europe Metastatic Bones Cancer Medication Treatment Market Size by Application (2022-2027)
7.3.3 Europe Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2027)
7.4 Europe Metastatic Bones Cancer Medication Treatment Market Size by Country
7.4.1 Europe Metastatic Bones Cancer Medication Treatment Market Size by Country (2016-2021)
7.4.2 Europe Metastatic Bones Cancer Medication Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size (2016-2027)
8.2 Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Type
8.2.1 Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Application
8.3.1 Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Region
8.4.1 Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metastatic Bones Cancer Medication Treatment Market Size (2016-2027)
9.2 Latin America Metastatic Bones Cancer Medication Treatment Market Size by Type
9.2.1 Latin America Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Metastatic Bones Cancer Medication Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2027)
9.3 Latin America Metastatic Bones Cancer Medication Treatment Market Size by Application
9.3.1 Latin America Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Metastatic Bones Cancer Medication Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2027)
9.4 Latin America Metastatic Bones Cancer Medication Treatment Market Size by Country
9.4.1 Latin America Metastatic Bones Cancer Medication Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Metastatic Bones Cancer Medication Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size (2016-2027)
10.2 Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Type
10.2.1 Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Application
10.3.1 Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Country
10.4.1 Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Metastatic Bones Cancer Medication Treatment Introduction
11.1.4 Amgen Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Metastatic Bones Cancer Medication Treatment Introduction
11.2.4 Merck & Co Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
11.2.5 Merck & Co Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Metastatic Bones Cancer Medication Treatment Introduction
11.3.4 Roche Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Metastatic Bones Cancer Medication Treatment Introduction
11.4.4 Novartis Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Metastatic Bones Cancer Medication Treatment Introduction
11.5.4 Eli Lilly and Company Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
11.5.5 Eli Lilly and Company Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Metastatic Bones Cancer Medication Treatment Introduction
11.6.4 Bayer Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Details
11.7.2 Fresenius Kabi Business Overview
11.7.3 Fresenius Kabi Metastatic Bones Cancer Medication Treatment Introduction
11.7.4 Fresenius Kabi Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
11.7.5 Fresenius Kabi Recent Development
11.8 BTG plc
11.8.1 BTG plc Company Details
11.8.2 BTG plc Business Overview
11.8.3 BTG plc Metastatic Bones Cancer Medication Treatment Introduction
11.8.4 BTG plc Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
11.8.5 BTG plc Recent Development
11.9 Boston Scientific
11.9.1 Boston Scientific Company Details
11.9.2 Boston Scientific Business Overview
11.9.3 Boston Scientific Metastatic Bones Cancer Medication Treatment Introduction
11.9.4 Boston Scientific Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
11.9.5 Boston Scientific Recent Development
11.10 Medtronic
11.10.1 Medtronic Company Details
11.10.2 Medtronic Business Overview
11.10.3 Medtronic Metastatic Bones Cancer Medication Treatment Introduction
11.10.4 Medtronic Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
11.10.5 Medtronic Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metastatic Bones Cancer Medication Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Hormone Therapy
Table 4. Key Players of Bisphosphonates
Table 5. Key Players of Opiate Therapy
Table 6. Key Players of Immunotherapy
Table 7. Global Metastatic Bones Cancer Medication Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Metastatic Bones Cancer Medication Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Metastatic Bones Cancer Medication Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Metastatic Bones Cancer Medication Treatment Market Share by Regions (2016-2021)
Table 11. Global Metastatic Bones Cancer Medication Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Metastatic Bones Cancer Medication Treatment Market Share by Regions (2022-2027)
Table 13. Metastatic Bones Cancer Medication Treatment Market Trends
Table 14. Metastatic Bones Cancer Medication Treatment Market Drivers
Table 15. Metastatic Bones Cancer Medication Treatment Market Challenges
Table 16. Metastatic Bones Cancer Medication Treatment Market Restraints
Table 17. Global Metastatic Bones Cancer Medication Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Metastatic Bones Cancer Medication Treatment Market Share by Players (2016-2021)
Table 19. Global Top Metastatic Bones Cancer Medication Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Bones Cancer Medication Treatment as of 2020)
Table 20. Ranking of Global Top Metastatic Bones Cancer Medication Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Metastatic Bones Cancer Medication Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Metastatic Bones Cancer Medication Treatment Product Solution and Service
Table 24. Date of Enter into Metastatic Bones Cancer Medication Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Metastatic Bones Cancer Medication Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Metastatic Bones Cancer Medication Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Metastatic Bones Cancer Medication Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Metastatic Bones Cancer Medication Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Metastatic Bones Cancer Medication Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Metastatic Bones Cancer Medication Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Metastatic Bones Cancer Medication Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Metastatic Bones Cancer Medication Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Metastatic Bones Cancer Medication Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Metastatic Bones Cancer Medication Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Metastatic Bones Cancer Medication Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Metastatic Bones Cancer Medication Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Metastatic Bones Cancer Medication Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Metastatic Bones Cancer Medication Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Metastatic Bones Cancer Medication Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Metastatic Bones Cancer Medication Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Metastatic Bones Cancer Medication Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Metastatic Bones Cancer Medication Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Metastatic Bones Cancer Medication Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Metastatic Bones Cancer Medication Treatment Product
Table 67. Amgen Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021) & (US$ Million)
Table 68. Amgen Recent Development
Table 69. Merck & Co Company Details
Table 70. Merck & Co Business Overview
Table 71. Merck & Co Metastatic Bones Cancer Medication Treatment Product
Table 72. Merck & Co Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021) & (US$ Million)
Table 73. Merck & Co Recent Development
Table 74. Roche Company Details
Table 75. Roche Business Overview
Table 76. Roche Metastatic Bones Cancer Medication Treatment Product
Table 77. Roche Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021) & (US$ Million)
Table 78. Roche Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Metastatic Bones Cancer Medication Treatment Product
Table 82. Novartis Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Eli Lilly and Company Company Details
Table 85. Eli Lilly and Company Business Overview
Table 86. Eli Lilly and Company Metastatic Bones Cancer Medication Treatment Product
Table 87. Eli Lilly and Company Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021) & (US$ Million)
Table 88. Eli Lilly and Company Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Metastatic Bones Cancer Medication Treatment Product
Table 92. Bayer Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Fresenius Kabi Company Details
Table 95. Fresenius Kabi Business Overview
Table 96. Fresenius Kabi Metastatic Bones Cancer Medication Treatment Product
Table 97. Fresenius Kabi Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021) & (US$ Million)
Table 98. Fresenius Kabi Recent Development
Table 99. BTG plc Company Details
Table 100. BTG plc Business Overview
Table 101. BTG plc Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021) & (US$ Million)
Table 102. BTG plc Recent Development
Table 103. Boston Scientific Company Details
Table 104. Boston Scientific Business Overview
Table 105. Boston Scientific Metastatic Bones Cancer Medication Treatment Product
Table 106. Boston Scientific Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021) & (US$ Million)
Table 107. Boston Scientific Recent Development
Table 108. Medtronic Company Details
Table 109. Medtronic Business Overview
Table 110. Medtronic Metastatic Bones Cancer Medication Treatment Product
Table 111. Medtronic Revenue in Metastatic Bones Cancer Medication Treatment Business (2016-2021) & (US$ Million)
Table 112. Medtronic Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Bones Cancer Medication Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Hormone Therapy Features
Figure 4. Bisphosphonates Features
Figure 5. Opiate Therapy Features
Figure 6. Immunotherapy Features
Figure 7. Global Metastatic Bones Cancer Medication Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Metastatic Bones Cancer Medication Treatment Report Years Considered
Figure 12. Global Metastatic Bones Cancer Medication Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Metastatic Bones Cancer Medication Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Metastatic Bones Cancer Medication Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Metastatic Bones Cancer Medication Treatment Market Share by Regions (2022-2027)
Figure 16. Global Metastatic Bones Cancer Medication Treatment Market Share by Players in 2020
Figure 17. Global Top Metastatic Bones Cancer Medication Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Bones Cancer Medication Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Metastatic Bones Cancer Medication Treatment Revenue in 2020
Figure 19. Global Metastatic Bones Cancer Medication Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Metastatic Bones Cancer Medication Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Metastatic Bones Cancer Medication Treatment Market Share by Type (2016-2027)
Figure 23. North America Metastatic Bones Cancer Medication Treatment Market Share by Application (2016-2027)
Figure 24. North America Metastatic Bones Cancer Medication Treatment Market Share by Country (2016-2027)
Figure 25. United States Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Metastatic Bones Cancer Medication Treatment Market Share by Type (2016-2027)
Figure 29. Europe Metastatic Bones Cancer Medication Treatment Market Share by Application (2016-2027)
Figure 30. Europe Metastatic Bones Cancer Medication Treatment Market Share by Country (2016-2027)
Figure 31. Germany Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Metastatic Bones Cancer Medication Treatment Market Share by Region (2016-2027)
Figure 41. China Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Metastatic Bones Cancer Medication Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Metastatic Bones Cancer Medication Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Metastatic Bones Cancer Medication Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Metastatic Bones Cancer Medication Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Metastatic Bones Cancer Medication Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
Figure 61. Merck & Co Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
Figure 66. Fresenius Kabi Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
Figure 67. BTG plc Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
Figure 68. Boston Scientific Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
Figure 69. Medtronic Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---